Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2021-07-14 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings
2021-07-14 English
Outcome of Board Meeting
Regulatory Filings
2021-07-14 English
Reply to Clarification- Financial results
Regulatory Filings
2021-07-12 English
Publish Audited Results
Regulatory Filings
2021-07-02 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (79 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, this document cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without specific content.
2021-07-02 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed disclosure under SEBI regulations about the audited financial results for the quarter and year ended 31 March 2021. It includes comprehensive financial statements such as the statement of assets and liabilities, cash flow statement, auditor's report, and declaration of unmodified opinion. The presence of full financial data, audit report, and the approval by the Board of Directors indicates this is the actual financial report for the fiscal year, not just an announcement or summary. The document length is substantial (15,000 characters), and it contains detailed financial tables and notes. Therefore, this document fits the definition of an Annual Report (10-K equivalent) or a full-year audited financial report. Given the Indian context and SEBI regulations, this is the annual audited financial results report, best classified as Annual Report (10-K). FY 2021
2021-06-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.